NCT05790941

Proof of Concept Study of Latanoprost/Minoxidil (ANR-001.1) Topical Formulation

Proof of Concept of Latanoprost/Minoxidil (ANR-001.1) Topical Formulation for Eyebrows

• Status: Unknown
• Phase: EARLY_Phase 1
• Study type: Interventional
• Enrollment: 12 (estimated)
• Sponsor: Aneira Pharma, Inc. · Industry
• Sex: All
• Age: 22 Years – 65 Years
• Healthy volunteers: Accepted

Summary

Study to Evaluate the safety and efficacy of a Latanoprost/Minoxidil formulation vs. placebo for the treatment of hypotrichosis of the eyebrows.

Detailed description

A Single-Blind placebo controlled trial of the efficacy and safety of the treatment of hypotrichosis of the eyebrows comparing a subset of patients receiving a combination of latanoprost/minoxidil formulation as compared to placebo measured by a validated imaging system.

Conditions

• Hypotrichosis

Interventions

Type	Name	Description
COMBINATION_PRODUCT	Latanoprost and Minoxidil	Latanoprost and Minoxidil formulation for the treatment of hypotrichosis of the eyebrows.

Timeline

• Start date: 2023-03-11
• Primary completion: 2023-06-30
• Completion: 2023-06-30
• First posted: 2023-03-30
• Last updated: 2023-03-30

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study